Drug Name Imbruvica (Ibrutinib ) Drug Class Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Oncology Risk Risk of hepatitis B reactivation Dear Healthcare provider letter DHPC